TN2010000232A1 - Formulations for cancer treatment - Google Patents
Formulations for cancer treatmentInfo
- Publication number
- TN2010000232A1 TN2010000232A1 TN2010000232A TN2010000232A TN2010000232A1 TN 2010000232 A1 TN2010000232 A1 TN 2010000232A1 TN 2010000232 A TN2010000232 A TN 2010000232A TN 2010000232 A TN2010000232 A TN 2010000232A TN 2010000232 A1 TN2010000232 A1 TN 2010000232A1
- Authority
- TN
- Tunisia
- Prior art keywords
- formulations
- cancer treatment
- provides
- kits
- matter
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- KLGQWSOYKYFBTR-UHFFFAOYSA-N 2-nitrobenzamide Chemical class NC(=O)C1=CC=CC=C1[N+]([O-])=O KLGQWSOYKYFBTR-UHFFFAOYSA-N 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides compositions of matter, kits, and methods for use in treating cancer and viral conditions. In particular the invention provides for pharmaceutical compositions containing nitrobenzamide compounds that have enhanced solubility in aqueous solutions.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TN2010000232A TN2010000232A1 (en) | 2010-05-21 | 2010-05-21 | Formulations for cancer treatment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TN2010000232A TN2010000232A1 (en) | 2010-05-21 | 2010-05-21 | Formulations for cancer treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2010000232A1 true TN2010000232A1 (en) | 2011-11-11 |
Family
ID=54695896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TN2010000232A TN2010000232A1 (en) | 2010-05-21 | 2010-05-21 | Formulations for cancer treatment |
Country Status (1)
| Country | Link |
|---|---|
| TN (1) | TN2010000232A1 (en) |
-
2010
- 2010-05-21 TN TN2010000232A patent/TN2010000232A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2009000292A1 (en) | Formulations for cancer treatment | |
| PH12013500238B1 (en) | N-acylsulfonamide apoptosis promoters | |
| PH12017501306A1 (en) | Inhibitors of histone demethylases | |
| PH12014501738A1 (en) | Piperidino-pyrimidine derivatives for the treatment of viral infections | |
| GB201118656D0 (en) | New compounds | |
| MX2020010535A (en) | Methods of treating cancer. | |
| MX2015006478A (en) | Glutamase inhibitors and method of use. | |
| PH12015501648A1 (en) | 2-aminopyrimidine derivatives for the treatment of viral infections | |
| MX2016002544A (en) | Compounds useful as immunomodulators. | |
| EP4230264A3 (en) | Prodrugs of fumarates and their use in treating various deseases | |
| PH12015500724A1 (en) | 1, 2, 4-triazine derivatives for the treatment of viral infections | |
| MX2011010390A (en) | Polymer-agent conjugates, particles, compositions, and related methods of use. | |
| IN2015MN00478A (en) | ||
| IN2015DN01156A (en) | ||
| UA115983C2 (en) | Dna-pk inhibitors | |
| GB201209613D0 (en) | New compounds | |
| EA201890754A1 (en) | CONNECTIONS AND METHODS OF THEIR APPLICATION | |
| MX366899B (en) | New compounds. | |
| HK1204970A1 (en) | Polymer-agent conjugates, particles, compositions, and related methods of use | |
| GB2507700A (en) | Compositions and methods for treatment of metastatic cancer | |
| MX356102B (en) | Compounds and methods for treating leukemia. | |
| TN2010000232A1 (en) | Formulations for cancer treatment | |
| SA515360233B1 (en) | Inhibitors of histone demethylases |